Literature DB >> 2670259

Jejunoileal bypass arthritis.

C B Ross, H W Scott, T Pincus.   

Abstract

Although intestinal bypass procedures are no longer performed, important lessons have been learned concerning clinical arthritides resulting from bacterial overgrowth and immune complex deposition. This information is of considerable value in patients who present with the clinical picture of intestinal bypass arthritis on the basis of other bowel abnormalities. Furthermore, the pathogenetic mechanisms involving bacterial overgrowth, release of bacterial antigens, and immune complex deposition may be pertinent to many types of inflammatory arthritis.

Entities:  

Mesh:

Year:  1989        PMID: 2670259     DOI: 10.1016/s0950-3579(89)80025-1

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  6 in total

Review 1.  The microbiome and rheumatoid arthritis.

Authors:  Jose U Scher; Steven B Abramson
Journal:  Nat Rev Rheumatol       Date:  2011-08-23       Impact factor: 20.543

Review 2.  Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis.

Authors:  Ethan Craig; Laura C Cappelli
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 3.  Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

Authors:  Jose U Scher; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2016-01       Impact factor: 10.995

4.  Small intestinal bacterial overgrowth in patients with rheumatoid arthritis.

Authors:  A E Henriksson; L Blomquist; C E Nord; T Midtvedt; A Uribe
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

Review 5.  Benchmarking best practices in weight loss surgery.

Authors:  Robert B Lim; George L Blackburn; Daniel B Jones
Journal:  Curr Probl Surg       Date:  2010-02       Impact factor: 1.909

Review 6.  Oral-Gut Microbiota and Arthritis: Is There an Evidence-Based Axis?

Authors:  Drago Lorenzo; Zuccotti GianVincenzo; Romanò Carlo Luca; Goswami Karan; Villafane Jorge; Mattina Roberto; Parvizi Javad
Journal:  J Clin Med       Date:  2019-10-22       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.